Pathologic findings of the placenta and clinical implications - recommendations for placental examination.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
14 Oct 2024
Historique:
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: epublish

Résumé

The placenta is a unique and complex organ that combines the circulatory systems of two or more individuals within a single dynamic organ with a set, short lifespan. A diverse spectrum of disorders, including infections as well as metabolic, genetic, circulatory, and maturation defects, may affect its function. Pathology investigation of the placenta is key for identifying several pathogenic processes in both the mother and the foetus. Aberrant placentation, maternal and foetal vascular compromise, infection, inflammatory immunologic conditions, and disorders of maturation are elements of newly proposed classification schemes. The clinical impact of placental examination consists of diagnosing maternal and foetal disease, identifying the potential for recurrence, correlating clinical pathological findings with distinct morphologic features, and identifying the aetiology responsible for growth restriction or foetal death. Gestational trophoblastic disease occurs more frequently in the first trimester; however, in very rare cases, it can affect the term or third-trimester placenta. The application of reproducible nomenclature is expected to facilitate progress in the diagnosis and treatment of obstetric and foetal disorders with placental manifestation. Therefore, this review aims to facilitate communication between obstetricians, neonatologists, and pathologists involved in this diagnostic process.

Identifiants

pubmed: 39465447
pii: 3929
doi: 10.57187/s.3929
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3929

Auteurs

Thomas Menter (T)

Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.

Elisabeth Bruder (E)

Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.

Irene Hösli (I)

Department of Obstetrics, University Hospital Basel, Basel, Switzerland.

Olav Lapaire (O)

Department of Obstetrics, University Hospital Basel, Basel, Switzerland.

Luigi Raio (L)

Department of Obstetrics and Gynaecology, University Hospital of Bern, Inselspital, Bern, Switzerland.

Henning Schneider (H)

Department of Obstetrics and Gynaecology, University Hospital of Bern, Inselspital, Bern, Switzerland.

Sylvia Höller (S)

Department of Pathology, Triemli Hospital, Zurich, Switzerland.

Roland Hentschel (R)

Division of Neonatology/Intensive Care Medicine, Department of General Pediatrics, Medical Center, University of Freiburg, Freiburg, Germany.

Simone Brandt (S)

Pathologie Zentrum Zürich medica, Zurich, Switzerland.
Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.

Peter Bode (P)

Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
Kantonsspital Winterthur, Winterthur, Switzerland.

Sven Schultzke (S)

Department of Neonatology, University Children's Hospital Basel UKBB, Basel, Switzerland.

Gero Drack (G)

Department of Obstetrics and Gynaecology, Kantonsspital St. Gallen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH